Vienna-based Ketryx secures $39 million Series B to scale AI compliance platform for medical software

Ketryx, an Austrian deep-tech startup based in Vienna, has secured $39 million in Series B funding as part of its efforts to expand its artificial intelligence-powered compliance platform for medical technology software. The latest round brings the company’s total funding to $55 million, reflecting growing investor confidence in its mission to streamline regulatory documentation in the highly regulated healthcare sector.

The Vienna-based company has developed a solution that leverages artificial intelligence to significantly reduce the administrative burden faced by teams developing regulated medical software. According to the company, its platform can decrease documentation workload by up to 90 percent—a substantial efficiency gain for organizations navigating complex compliance requirements in the medical device and healthcare software industries.

Addressing a critical industry pain point

Regulatory compliance remains one of the most resource-intensive aspects of medical software development. Teams must maintain extensive documentation to satisfy requirements from bodies such as the FDA and European regulatory authorities. Ketryx’s AI-driven approach automates much of this documentation process, allowing development teams to focus on core product functionality and innovation rather than administrative overhead.

“We help teams build mission-critical and life-saving software with the help of AI,” said Jan Pöschko, emphasizing the company’s commitment to supporting the creation of healthcare software that directly impacts patient outcomes.

Scaling operations and expanding capabilities

The Series B funding will enable Ketryx to scale its product offering and add post-sales capabilities to better serve its growing customer base. The company currently employs approximately 40 people in Vienna, positioning itself as a significant player within Austria’s emerging deep-tech ecosystem.

The investment underscores the increasing recognition of artificial intelligence’s potential to solve compliance challenges in highly regulated industries. Rather than replacing human expertise, Ketryx’s technology augments development teams by automating routine documentation tasks, freeing skilled professionals to concentrate on higher-value activities.

Strengthening European healthtech innovation

The funding achievement reflects broader momentum in the European healthtech sector, where startups are increasingly developing sophisticated software solutions to address inefficiencies in medical device development and healthcare delivery. Vienna has emerged as a noteworthy hub for deep-tech innovation, particularly in areas where regulatory compliance and advanced technology intersect.

Companies like Ketryx demonstrate how European startups are tackling real-world problems faced by the medical technology industry. As regulatory requirements continue to evolve globally, demand for intelligent compliance solutions is likely to accelerate, positioning early movers in this space for sustained growth. The company’s $55 million in total funding positions it to capture a meaningful share of this expanding market opportunity across Europe and beyond.

Leave a Comment